Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Eflornithine × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 6 Sarcoma, Ewing 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive 2 Medulloblastoma 2 Typical Teratoid Rhabdoid Tumor 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteosarcoma Recurrent 1 Melanoma 1 Lung Neoplasms 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

cemiplimab 5 Nivolumab 4 pembrolizumab 3 Specimen Handling 3 Radiotherapy 3 Biopsy 3 Surgical Procedures, Operative 2 Standard of Care 2 Photochemotherapy 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Aminolevulinic Acid 2 tocilizumab 1 talimogene laherparepvec 1 sonidegib 1 relatlimab 1 prednylidene 1 poly ICLC 1 methyl 5-aminolevulinate 1 flt3 ligand protein 1 deltacortene 1 daromun 1 Watchful Waiting 1 Vitamin D 1 Tomography, Optical Coherence 1 Sunscreening Agents 1 Sirolimus 1 Risk Factors 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡